Bakkenolide B is primarily studied for its potential neuroprotective and anti-inflammatory properties. It has shown promise in research related to central nervous system disorders, where it may help reduce neuronal damage caused by oxidative stress and inflammation. Studies suggest it can modulate signaling pathways involved in neuroinflammation, making it a compound of interest in the development of treatments for neurodegenerative conditions such as Alzheimer's and Parkinson’s disease. Additionally, Bakkenolide B exhibits inhibitory effects on platelet-activating factor (PAF), which plays a role in inflammatory and allergic responses, indicating possible applications in managing inflammatory diseases. Its natural origin and bioactivity also make it a candidate for further exploration in phytochemical-based therapeutics.